Skip to content
2000
Volume 1, Issue 2
  • ISSN: 2213-8099
  • E-ISSN: 2213-8102

Abstract

The pharmaceutical industry heavily relies on external sources to supplement its internal R&D activities and fill its product pipelines. Outsourcing of workpackages, in-licensing of development projects, collaborations with academic research centers or biotech companies and hiring of consultants are classic approaches towards this goal. Here we describe a new open innovation approach, termed “fluctuating open teams (FLOT)” that combines synergistically internal and external talent for a drug discovery project. The approach is compared to other open innovation options and constitutes an ideal way to boost creativity and new ideas for project teams that hit a roadblock.

Loading

Article metrics loading...

/content/journals/tte/10.2174/2213809901666140401202431
2014-10-01
2025-12-15
Loading full text...

Full text loading...

/content/journals/tte/10.2174/2213809901666140401202431
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test